Glikman Urological & Kidney Institute, Cleveland, Clinic, Cleveland, OH, USA
Rossella Cannarella, MD, PhD, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
Dr. Rossella Cannarella is an Endocrinology specialist and a European Academy of Andrology (EAA) certified Clinical Andrologist who has carried out her internship at the Division of Endocrinology, Metabolic Diseases and Nutrition, University of Catania (Italy), an EAA Training Center, directed by her research mentor, Prof. Aldo E Calogero. In 2022, she received her international PhD in Translational Biomedicine from the University of Catania. She was appointed Research Fellow at the Glickman Urological & Kidney Institute, Cleveland Clinic Foundation, Cleveland (OH, USA).
Dr. Cannarella spent more than 15 years training in the field of endocrinology, male infertility, and human reproduction. During her residency in Endocrinology, she joined Summer Schools organized by the EAA leading Center in Testicular Histology (Zagreb, Croatia), where she gained knowledge on human testicular histopathology. She also joined and collaborated with colleagues of the University of Perugia (Italy), experts in culturing neonatal porcine Sertoli cells, where she developed research protocols aimed at understanding the impact of growth factors (i.e. insulin, IGF1, etc.) on the function of these cells. More recently, she has begun to focus on sperm epigenetics and transcriptome.
As a visiting scholar at the University of Massachusetts Medical School (Worcester, MA, USA), she spent six months studying the role of sperm-derived transcripts on parthenotes gene expression in mice, a project for which she was awarded by the European Society of Human Reproduction and Embryology (ESHRE) in 2020. In 2023 she was awarded at ASRM2023 with the Lipschultz/Lamb Traveling Scholar Award. In 2024 she won the 2024 ASRM Pilot & Exploratory competitive Grant as PI, with the project “Role of Low Sperm IGF2 Expression Levels in Male Infertility: A New Cause of Poor Early Embryo Development”. She has been elected as member of the Endocrine Disrupting Chemicals (EDC) SIG Steering Committee of the Endocrine Society in 2024.
Dr. Cannarella has participated as a guest lecturer in over 50 national and international meetings on male infertility and human reproduction, including ENDO2022 (Atlanta, GE, USA), SIU2022 (Montreal, Canada), ASRM2023 (New Orleans, LA, USA), ENDO2023 (Chicago, IL, USA), IVIRMA Congress 10th edition (Malaga, Spain), ENDO2024 (Boston, MA, USA), NACFC2024 (Boston, MA, USA). She has been invited as a speaker at the 2025 ESHRE Campus on Personalized Medicine (Berlin, Germany).
She is a member of the Editorial Board of four peer-reviewed and indexed journals (BMC Urology, International Journal of Molecular Science, Minerva Endocrinology, Asian Journal of Andrology), and Associate Editor of the Endocrinology section of Heliyon (Cell Press) and of Frontiers in Endocrinology - section Reproduction. She has published 221 articles in indexed, peer-reviewed journals and has an h-index of 27 (Scopus, 24/6/2024).
Dr. Cannarella’s research interests include the role of FSH in the treatment of male infertility, the genetics of spermatogenic failure, the effects of growth factors on immature Sertoli cells, testicular function in childhood, and the role of sperm-derived transcripts in embryo development. Her clinical interests include the management of infertile male patients, varicocele, male accessory gland infection/inflammation, hypogonadism, gynecologic endocrinology, metabolic diseases, and general endocrinology.
Thursday, September 26, 2024
10:15 AM – 12:15 PM ET